SHZ Healthcare Medical - Instruments & Supplies 300896.SZ

Imeik Technology Development Co.,Ltd.

$ 91.36 0.48 %

Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.

CEO: Yifeng Shi - https://www.imeik.net

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 214.65

Loading data...

300896.SZ vs S&P500

Loading data...

No data available.

Quick ratio

7.04

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

24.04

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

3.80

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

15.12 %

reflects reasonable profitability, showing good use of equity.

ROIC

12.75 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

7.54

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.03

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

3.85

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

131.57 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
26.35 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
2.66 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.03 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.